CHRS
Coherus Oncology, Inc. Common Stock
$1.33
-6.99%
-0.10
Notify me if price changes either direction
Buy CHRS stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
220.9M
Enterprise value
154.4M
Trailing PE
3.0727272
Forward PE
-2.1111112
PEG Ratio
-0.029247810755556
Enterprise to EBITDA
-1.026
Enterprise to revenue
3.03
Price to book MRQ
3.3756347
Price to sales TTM
4.0342054
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-06-30
Revenue (TTM)
50.9M
EBITDA
-150390000
Diluted EPS TTM
-1.24
Total Cash (MRQ)
105.3M
Current ratio (MRQ)
1.772
Operating Cash Flow (TTM)
-186031008
CHRS trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
September 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
